REVIEW PAPER
Adherence to anti-retroviral therapy during COVID-19 pandemic among adolescents born HIV-positive
1
Nelson Mandela University, South Africa
Submission date: 2020-11-16
Final revision date: 2021-06-01
Acceptance date: 2021-06-02
Publication date: 2021-09-30
HIV & AIDS Review 2021;20(3):166-172
KEYWORDS
TOPICS
ABSTRACT
Successful rollout of anti-retroviral therapy (ART) in Africa has resulted in a steep decline in HIV incidence. Even though this has been a long-awaited development, it is not the case for adolescents (10-19 years) born HIV-positive. Given this brief background and dangers imposed by COVID-19 pandemic, adolescents born HIV-positive are at great risk. A systematic review was conducted and reported, according to preferred reporting items for meta-analyses (PRISMA). Studies were drawn from database search performed between April and June 2020 using PsycINFO, Google Scholar, and Sabinet. Results suggested that factors, which negatively impact ART adherence fall into three main levels:
1. Household level: through pressure to share medication; 2. Institutional level: lockdown restrictions due to COVID-19, long distance to facilities, heavy workload due to limited staff, and extended waiting times; 3. Community level: structural barriers, such as HIV stigma and discrimination, gender inequalities, and poor living conditions. Main motivators to remain adherent to ART include having a strong social support system, life goals, and ambitions. This paper highlights the complexity of ART adherence during COVID-19 pandemic. Interventions to improve adherence to ART of adolescents born HIV-positive should address psycho-social factors, such as treatment fatigue, disclosure and family, and household dynamics, in addition to access to ART service delivery during periods of crisis.
1. Household level: through pressure to share medication; 2. Institutional level: lockdown restrictions due to COVID-19, long distance to facilities, heavy workload due to limited staff, and extended waiting times; 3. Community level: structural barriers, such as HIV stigma and discrimination, gender inequalities, and poor living conditions. Main motivators to remain adherent to ART include having a strong social support system, life goals, and ambitions. This paper highlights the complexity of ART adherence during COVID-19 pandemic. Interventions to improve adherence to ART of adolescents born HIV-positive should address psycho-social factors, such as treatment fatigue, disclosure and family, and household dynamics, in addition to access to ART service delivery during periods of crisis.
REFERENCES (62)
1.
Nyoni T, Okumu M. COVID-19-compliant strategies for supporting treatment adherence among people living with HIV in Sub-Saharan Africa. AIDS Behav 2020. DOI: 10.1007/s10461-020-02888-0.
3.
Alcorn K. People with HIV at greater risk of COVID-19 death in South African study. 2020. Available at: https://www.aidsmap.com/news/j... (Accessed: 20.05.2020).
4.
Alcorn K. HIV raises the risk of death from COVID-19 in South Africa’s Western Cape. 2020. Available at: https://www.aidsmap.com/news/j... (Accessed: 20.05.2020).
5.
Bandason T, Langhaug LF, Makamba M, et al. Burden of HIV among primary school children and feasibility of primary school-.
6.
linked HIV testing in Harare, Zimbabwe: a mixed methods study. AIDS Care 2013; 25: 1520-1526.
7.
Ferrand RA, Munaiwa L, Matsekete J, et al. Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe. Clin Infect Dis 2010; 51: 844-851.
8.
Judd A, Doerholt K, Tookey PA, et al. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis 2007; 45: 918-924.
9.
Ferrand RA, Corbett EL, Wood R, et al. AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS (London, England) 2009; 23: 2039.
10.
Sarna A, Chersich M, Okal J, et al. Changes in sexual risk taking with antiretroviral treatment: influence of context and gender norms in Mombasa, Kenya. Cult Health Sex 2009; 11: 783-797.
11.
Bandura A. Comments on the crusade against the causal efficacy of human thought. J Behav Ther Exp Psychiatry 1995; 26: 179-190.
12.
Snyder CR, Lopez SJ (eds.). Handbook of Positive Psychology. Oxford University Press; 2001.
13.
Lunenburg FC. Self-efficacy in the workplace: implications for motivation and performance. International Journal of Management, Business, and Administration 2011; 14: 1-6.
14.
Redmond BF. Self-efficacy theory: do I think that I can succeed in my work? Work attitudes and motivation. The Pennsylvania State University, World Campus; 2010.
15.
Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977; 84: 191.
16.
Williams T, Williams K. Self-efficacy and performance in mathematics: reciprocal determinism in 33 nations. Journal of Educational Psychology 2010; 102: 453.
17.
Weed M. A potential method for the interpretive synthesis of qualitative research: issues in the development of ‘meta-interpretation’. International Journal of Social Research Methodology 2008; 11: 13-28.
18.
Krauss BJ, Letteney S, Okoro CN. Why tell children: a synthesis of the global literature on reasons for disclosing or not disclosing an HIV diagnosis to children 12 and under. Front Public Health 2016; 4: 181.
19.
Micheni M, Kombo BK, Secor A, et al. Health provider views on improving antiretroviral therapy adherence among men who have sex with men in coastal Kenya. AIDS Patient Care STDs 2017; 31: 113-121.
20.
Nabukeera-Barungi N, Elyanu P, Asire B, et al. Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda. BMC Infect Dis 2015; 15: 520.
21.
Hall LH, Johnson J, Watt I, Tsipa A, O’Connor DB. Healthcare staff wellbeing, burnout, and patient safety: a systematic review. PLoS One 2016; 11: e0159015.
22.
Jaffar S, Amuron B, Foster S, et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 2009; 374: 2080-2089.
24.
Integrating evidence and context to develop a parenting program for low-income families in South Africa. Journal of Child and Family Studies 2016; 25: 2337-2352.
25.
Mavhu W, Berwick J, Chirawu P, et al. Enhancing psychosocial support for HIV positive adolescents in Harare, Zimbabwe. PLoS One 2013; 8: e70254.
26.
Skovdal M, Magutshwa-Zitha S, Campbell C, Nyamukapa C, Gregson S. Community groups as ‘critical enablers’ of the HIV response in Zimbabwe. BMC Health Services Research 2013; 13: 195.
29.
Robson E, Ansell N, Huber US, Gould WT, van Blerk L. Young caregivers in the context of the HIV/AIDS pandemic in sub‐Saharan Africa. Population, Space and Place 2006; 12: 93-111.
30.
Andrews G, Skinner D, Zuma K. Epidemiology of health and vulnerability among children orphaned and made vulnerable by HIV/AIDS in sub-Saharan Africa. AIDS Care 2006; 18: 269-276.
31.
Geng EH, Bangsberg DR, Musinguzi N, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 2010; 53: 405-411.
32.
Amuron B, Namara G, Birungi J, et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 2009; 9: 290.
33.
Garvie PA, Wilkins ML, Young JC. Medication adherence in adolescents with behaviorally-acquired HIV: evidence for using a multimethod assessment protocol. J Adolesc Health 2010; 47: 504-511.
34.
Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther 2016; 13: 1-7.
36.
up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 2009; 9: 290.
37.
Unge C, Södergård B, Marrone G, et al. Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study. PLoS One 2010; 5: e13613.
38.
Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 2007; 19: 658-665.
39.
Young S, Wheeler AC, McCoy SI, Weiser SD. A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS Behav 2014; 18: 505-515.
40.
Madiba S, Josiah U. Perceived stigma and fear of unintended disclosure are barriers in medication adherence in adolescents with perinatal HIV in Botswana: a qualitative study. Biomed Res Int 2019; 2019: 9623159.
41.
Maskew M, Fox MP, Evans D, et al. Insights into adherence among a cohort of adolescents aged 12-20 years in South Africa: reported barriers to antiretroviral treatment. AIDS Res Treat 2016; 2016: 4161738.
42.
Nyoni T, Okumu M. COVID-19-compliant strategies for supporting treatment adherence among people living with HIV in sub-Saharan Africa. AIDS Behav 2020; 24: 2473-2476.
43.
Kolmodin MacDonell K, Jacques-Tiura AJ, Naar S, Fernandez MI, ATN 086/106 Protocol Team. Predictors of self-reported adherence to antiretroviral medication in a multisite study of ethnic and racial minority HIV-positive youth. J Pediatr Psychol 2016; 41: 419-428.
44.
Gray ME, Nieburg P, Dillingham R. Pediatric human immunodeficiency virus continuum of care: a concise review of evidence-based practice. Pediatr Clin North Am 2017; 64: 879-891.
45.
Schlatter AF, Deathe AR, Vreeman RC. The need for pediatric formulations to treat children with HIV. AIDS Res Treat 2016; 2016: 1654938.
46.
Giannattasio A, Albano F, Giacomet V, Guarino A. The changing pattern of adherence to antiretroviral therapy assessed at two time points, 12 months apart, in a cohort of HIV-infected children. Expert Opin Pharmacother 2009; 10: 2773-2778.
47.
Cluver L, Meinck F, Toska E, Orkin FM, Hodes R, Sherr L. Multitype violence exposures and adolescent antiretroviral nonadherence in South Africa. AIDS 2018; 32: 975-983.
48.
Cluver LD, Hodes RJ, Toska E, et al. ‘HIV is like a tsotsi. ARVs are your guns’: associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa. AIDS 2015; 29 Suppl 1: S57-65.
49.
Foster C, McDonald S, Frize G, Ayers S, Fidler S. “Payment by Results” – financial incentives and motivational interviewing, adherence interventions in young adults with perinatally acquired HIV-1 infection: a pilot program. AIDS Patient Care STDs 2014; 28: 28-32.
50.
Bucek A, Leu CS, Benson S, et al. Psychiatric disorders, antiretroviral medication adherence, and viremia in a cohort of perinatally HIV-.
52.
Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med 2014; 47: 259-269.
53.
Shaw S, Amico KR. Antiretroviral therapy adherence enhancing interventions for adolescents and young adults 13–24 years of age: a review of the evidence base. J Acquir Immune Defic Syndr 2016; 72: 387-399.
54.
Judd A, Sohn AH, Collins IJ. Interventions to improve treatment, retention and survival outcomes for adolescents with perinatal HIV-1 transitioning to adult care: moving on up. Curr Opin HIV AIDS 2016; 11: 477-46.
55.
Camacho-Gonzalez AF, Chernoff MC, Williams PL, et al. and International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1074 Study Team, 2017. J Pediatric Infect Dis Soc 2017; 6: e22-e29.
57.
Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr 2009; 51: 65-71.
58.
Heestermans T, Browne JL, Aitken SC, Vervoort SC, Klipstein-Grobusch K. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Global Health 2016; 1: e000125.
59.
Tassiopoulos K, Moscicki AB, Mellins C, Kacanek D, Malee K, Allison S. Pediatric HIV/AIDS Cohort Study. Sexual risk behavior among youth with perinatal HIV infection in the United States: predictors and implications for intervention development. Clin Infect Dis 2013; 56: 283-290.
60.
Bekker LG, Johnson L, Wallace M, Hosek S. Building our youth for the future. J Int AIDS Soc 2015; 18: 20027.
61.
Williams S, Renju J, Ghilardi L, Wringe A. Scaling a waterfall: a meta‐ethnography of adolescent progression through the stages of HIV care in sub‐Saharan Africa. J Int AIDS Soc 2017; 20: 21922.
62.
Larkan F, Van Wyk B, Stevens P, Saris AJ. Between the clinic and the community: Temporality and patterns of ART adherence in the Western Cape Province, South Africa. African Sociological Review 2015; 19: 26-52.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
